Avecia Biotechnology Inc., a leader in therapeutic nucleic acid manufacturing and development services, and a new member of the Nitto Denko Corporation, today announced the official launch of its OliGO- Faster, Smarter, BetterSM development program.
Avecia Biotechnology Inc., a leader in therapeutic nucleic acid manufacturing and development services, and a new member of the Nitto Denko Corporation, today announced the official launch of its OliGO- Faster, Smarter, BetterSM development program.
